Literature DB >> 25641483

Diagnostic-therapeutic pathway for small lesions of the testis.

Giulia Sbrollini1, Daniele Mazzaferro, Asim Ettamimi, Rodolfo Montironi, Marco Cordari, Guevar Maselli, Giacomo Tucci, Gaetano Donatelli, Francesco Pellegrinelli, Alessandro Conti, Andrea Benedetto Galosi.   

Abstract

Objective of our study was to define a diagnostic-therapeutic pathway for proper treatment of not-palpable testicular masses, that may be benign in 38% of cases. Since the intraoperative diagnosis is difficult to reach in particular in small lesion (< 8 mm) and the risk of tissue loss in frozen section analysis occurs frequently, we propose a diagnostic flow chart for the best management of small testis lesions. This proposed protocol has to be shown in details to physicians and patients, who must understand the clinical implications and the risk to undergo a second radical surgery.

Entities:  

Mesh:

Year:  2014        PMID: 25641483     DOI: 10.4081/aiua.2014.4.397

Source DB:  PubMed          Journal:  Arch Ital Urol Androl        ISSN: 1124-3562


  3 in total

1.  The role of tumor size, ultrasonographic findings, and serum tumor markers in predicting the likelihood of malignant testicular histology.

Authors:  Gang Song; Geng-Yan Xiong; Yu Fan; Cong Huang; Yong-Ming Kang; Guang-Jie Ji; Jin-Chao Chen; Zhong-Cheng Xin; Li-Qun Zhou
Journal:  Asian J Androl       Date:  2019 Mar-Apr       Impact factor: 3.285

2.  The sclerosing Sertoli cell tumor of the testis is an extremely rare entity.

Authors:  Faaz Salah Gomha; Kamran Hassan Bhatti; Ayad A Yousif; Ayamn Mohammed Smain; Nadeem Sohail; Khalid Mohammed Abdelrahman; Huma Arshad; Ahmed H A Shaat; Wasim Sarwar Bhatti; Naeem Ahmed Cheema
Journal:  Ther Adv Urol       Date:  2020-10-20

Review 3.  Applications of Focused Ultrasound in the Treatment of Genitourinary Cancers.

Authors:  John Panzone; Timothy Byler; Gennady Bratslavsky; Hanan Goldberg
Journal:  Cancers (Basel)       Date:  2022-03-17       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.